Glenn M. Chertow

Publication Details

• Challenges to enrollment and randomization of the Frequent Hemodialysis Network (FHN) Daily Trial.

  Sergeyeva O, Gorodetskaya I, Ramos R, Schiller BM, Larive B, Raimann JG, Ting GO, Eggers PW, Chertow GM, Levin NW. J Nephrol. 2012 May-Jun; 25 (3): 302-9

  The US National Institutes of Health (NIH) and Centers for Medicare and Medicaid Services (CMS) sponsored a randomized clinical trial comparing six versus three times per week in-center hemodialysis (the Frequent Hemodialysis Network [FHN] Daily Trial), to test the effects of frequent hemodialysis on an array of intermediate outcomes. Herein we report challenges to enrollment and randomization into the trial.

  PubMedID: 22505248